A New Generation of Medicine
Psygen is a manufacturer of pharmaceutical-grade psychedelic drug products for clinical research and therapeutic applications
Download our Pitch DeckThe future of mental health and personal development is in psychedelics.
Pharmaceutical-Grade Products
Psychedelics for Clinical Research
Psygen’s mission is to accelerate the research and development of psychedelic drugs for medicinal and therapeutic applications.
Psygen's Social Mandate
We are committed to donating up to 10% of all profits to our charitable foundation to provide access to therapy for low income populations, fund non-profit research programs and fund environmental programs.
The Team
Danny graduated from the University of Victoria with a degree in chemistry before becoming an early employee at Aurora Cannabis. His career with Aurora provided foundational experience in enterprise management, good manufacturing practices, and the Controlled Drugs and Substances Act.
Dr. van der Heyden’s scientific focus is on cGMP manufacture of lysergamides, tryptamines and phenethylamines for use in clinical trials, and on biotechnological approaches to assembling precursors and psychedelic drug molecules.
An unconventional Chartered Accountant, Roger has gained a unique combination of entrepreneurial, leadership, financial and PR skills over the past 25 years while spearheading several rapidly growing private and public companies. Roger previously served as CEO of Rare Method and Jump On Flyaways as well as CFO of Resorts of the Canadian Rockies, Enerjet, New Leaf Travel and several start-up companies on a contract basis.
Nadia joined Psygen in February 2020 just prior to the launch of Psygen Labs. She took an immediate interest in amplifying the company's public dialogue, communications and sales. As the Director of Sales and Marketing, Nadia is streamlining our psychedelic sales process and developing relationships with valued clients.
For the last 18 years Nadia has worked on the front lines in EMS. After completing almost 6 years of education, she graduated with a Critical Care Flight Paramedic (CCP) qualification and has worked in emergency retrieval medicine since 2016. Slowing down to a part-time medic she is now focused on work with Psygen.
Bri graduated from the University of Calgary with a BSc in biochemistry and a PhD in physical chemistry. Her R&D experience is diverse with focuses on biomedical device development, petroleum and chemical engineering, agricultural chemical formulation and clean energy process development. Bri’s comprehensive technical, business and research background provide her with the fundamental experience to efficiently and effectively operate the state-of-the-art Psygen laboratory facilities.
Chris graduated from the Adam Mickiewicz University in Poland with a MSc in Chemistry.
His passion for helping improve the human experience through psychedelic manufacturing is backed by several years of experience of work with pharmaceuticals, nutraceuticals and medicinal marijuana.
Chris brings the implementation of safe manufacturing practices as required by Health Canada and his
expertise with Food and Food Supplements manufacturing regulations and their practical implementation make him well versed in this emerging market.
Mark Haden is Adjunct Professor of the UBC School of Population and Public Health. He is currently involved with the British Columbia Health Officers Council drug policy committee and provides public information on drugs and drug policy.